Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 May;82(9):2769–2773. doi: 10.1073/pnas.82.9.2769

Preferential binding of benzo[a]pyrene diol epoxide to the linker DNA of human foreskin fibroblasts in S phase in the presence of benzamide.

P Kurian, A M Jeffrey, G E Milo
PMCID: PMC397647  PMID: 3921965

Abstract

Addition of benzamide (BZ) at the onset of S phase inhibited expression of the neoplastic phenotype in human foreskin fibroblasts treated in vitro with (+/-)-7 alpha,8 beta-dihydroxy-9 beta,10 beta-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (B[a]P diol epoxide) in early S phase. Analysis of the specific B[a]P diol epoxide-DNA adducts revealed that ca. 65% of the total adducts in BZ and non-BZ carcinogen-treated cells was the B[a]P diol epoxide-deoxyguanine adduct. Limited micrococcal nuclease digestion of the early S phase nuclei from cells treated with B[a]P diol epoxide indicated that the carcinogen binds equally to linker and core DNA. However, when the cells were predominantly in S phase, in the presence of BZ, there was ca. three times more binding of B[a]P diol epoxide to the linker DNA compared to the core region. The confluent cells in G1 cell arrest treated only with B[a]P diol epoxide also bound the carcinogen preferentially to the linker region. These data indicate that pretreatment of the cells with BZ at the onset of S phase established a preferential binding pattern in the linker DNA similar to that observed in the cells treated with B[alpha]P diol epoxide in G1 arrest.

Full text

PDF
2769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROOKES P., LAWLEY P. D. EVIDENCE FOR THE BINDING OF POLYNUCLEAR AROMATIC HYDROCARBONS TO THE NUCLEIC ACIDS OF MOUSE SKIN: RELATION BETWEEN CARCINOGENIC POWER OF HYDROCARBONS AND THEIR BINDING TO DEOXYRIBONUCLEIC ACID. Nature. 1964 May 23;202:781–784. doi: 10.1038/202781a0. [DOI] [PubMed] [Google Scholar]
  2. Borek C., Morgan W. F., Ong A., Cleaver J. E. Inhibition of malignant transformation in vitro by inhibitors of poly(ADP-ribose) synthesis. Proc Natl Acad Sci U S A. 1984 Jan;81(1):243–247. doi: 10.1073/pnas.81.1.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cordeiro-Stone M., Topal M. D., Kaufman D. G. DNA in proximity to the site of replication is preferentially alkylated in S phase 10T1/2 cells treated with N-methyl-N-nitroso-urea. Carcinogenesis. 1982;3(10):1119–1127. doi: 10.1093/carcin/3.10.1119. [DOI] [PubMed] [Google Scholar]
  4. Craddock V. M., Frei J. V. Induction of liver cell adenomata in the rat by a single treatment with N-methyl-N-nitrosourea given at various times after partial hepatectomy. Br J Cancer. 1974 Dec;30(6):503–511. doi: 10.1038/bjc.1974.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HEIDELBERGER C., DAVENPORT G. R. Local functional components of carcinogenesis. Acta Unio Int Contra Cancrum. 1961;17:55–63. [PubMed] [Google Scholar]
  6. Hancock R. Assembly of new nucleosomal histones and new DNA into chromatin. Proc Natl Acad Sci U S A. 1978 May;75(5):2130–2134. doi: 10.1073/pnas.75.5.2130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jack P. L., Brookes P. Mechanism for the loss of preferential benzo [a] pyrene binding to the linker DNA of chromatin. Carcinogenesis. 1982;3(3):341–344. doi: 10.1093/carcin/3.3.341. [DOI] [PubMed] [Google Scholar]
  8. Jack P. L., Brookes P. The distribution of benzo(a)pyrene DNA adducts in mammalian chromatin. Nucleic Acids Res. 1981 Nov 11;9(21):5533–5552. doi: 10.1093/nar/9.21.5533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jeffrey A. M., Weinstein I. B., Jennette K. W., Grzeskowiak K., Nakanishi K., Harvey R. G., Autrup H., Harris C. Structures of benzo(a)pyrene--nucleic acid adducts formed in human and bovine bronchial explants. Nature. 1977 Sep 22;269(5626):348–350. doi: 10.1038/269348a0. [DOI] [PubMed] [Google Scholar]
  10. Kakunaga T. The role of cell division in the malignant transformation of mouse cells treated with 3-methylcholanthrene. Cancer Res. 1975 Jul;35(7):1637–1642. [PubMed] [Google Scholar]
  11. Kaneko M., Cerutti P. A. Excision of N-acetoxy-2-acetylaminofluorene-induced DNA adducts from chromatin fractions of human fibroblasts. Cancer Res. 1980 Nov;40(11):4313–4319. [PubMed] [Google Scholar]
  12. Kaneko M., Cerutti P. A. Excision of benzo[a]pyrene diol epoxide I adducts from nucleosomal DNA of confluent normal human fibroblasts. Chem Biol Interact. 1982 Feb;38(3):261–274. doi: 10.1016/0009-2797(82)90057-6. [DOI] [PubMed] [Google Scholar]
  13. Kaufmann W. K., Kaufman D. G., Rice J. M., Wenk M. L. Reversible inhibition of rat hepatocyte proliferation by hydrocortisone and its effect on cell cycle-dependent hepatocarcinogenesis by N-methyl-N-nitrosourea. Cancer Res. 1981 Nov;41(11 Pt 1):4653–4660. [PubMed] [Google Scholar]
  14. Kun E., Kirsten E., Milo G. E., Kurian P., Kumari H. L. Cell cycle-dependent intervention by benzamide of carcinogen-induced neoplastic transformation and in vitro poly(ADP-ribosyl)ation of nuclear proteins in human fibroblasts. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7219–7223. doi: 10.1073/pnas.80.23.7219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miller J. A. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. Cancer Res. 1970 Mar;30(3):559–576. [PubMed] [Google Scholar]
  16. Milo G. E., DiPaolo J. A. Presensitization of human cells with extrinsic signals to induced chemical carcinogenesis. Int J Cancer. 1980 Dec 15;26(6):805–812. doi: 10.1002/ijc.2910260615. [DOI] [PubMed] [Google Scholar]
  17. Milo G. E., Jr, DiPaolo J. A. Neoplastic transformation of human diploid cells in vitro after chemical carcinogen treatment. Nature. 1978 Sep 14;275(5676):130–132. doi: 10.1038/275130a0. [DOI] [PubMed] [Google Scholar]
  18. Oldham J. W., Allred L. E., Milo G. E., Kindig O., Capen C. C. The toxicological evaluation of the mycotoxins T-2 and T-2 tetraol using normal human fibroblasts in vitro. Toxicol Appl Pharmacol. 1980 Jan;52(1):159–168. doi: 10.1016/0041-008x(80)90255-0. [DOI] [PubMed] [Google Scholar]
  19. Phillips D. H. Fifty years of benzo(a)pyrene. Nature. 1983 Jun 9;303(5917):468–472. doi: 10.1038/303468a0. [DOI] [PubMed] [Google Scholar]
  20. Purnell M. R., Whish W. J. Novel inhibitors of poly(ADP-ribose) synthetase. Biochem J. 1980 Mar 1;185(3):775–777. doi: 10.1042/bj1850775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Seale R. L. Temporal relationships of chromatin protein synthesis, DNA synthesis, and assembly of deoxyribonucleoprotein. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2270–2274. doi: 10.1073/pnas.73.7.2270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sims P., Grover P. L., Swaisland A., Pal K., Hewer A. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature. 1974 Nov 22;252(5481):326–328. doi: 10.1038/252326a0. [DOI] [PubMed] [Google Scholar]
  23. Tejwani R., Jeffrey A. M., Milo G. E. Benzo[a]pyrene diol epoxide DNA adduct formation in transformable and non-transformable human foreskin fibroblast cells in vitro. Carcinogenesis. 1982;3(7):727–732. doi: 10.1093/carcin/3.7.727. [DOI] [PubMed] [Google Scholar]
  24. Yang L. L., Maher V. M., McCormick J. J. Error-free excision of the cytotoxic,mutagenic N2-deoxyguanosine DNA adduct formed in human fibroblasts by (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5933–5937. doi: 10.1073/pnas.77.10.5933. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES